Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Feiyan Qingjie Granules
- Development stage
- Unknown
- Lead developer
- Guangzhou Eighth People's Hospital
- Administration
- Oral
01
Overview
Feiyan Qingjie Granules is a Traditional Chinese Medicine (TCM) formulation developed by the Guangzhou Eighth People's Hospital. Originally known as "Feiyan No. 1," it was specifically formulated to treat viral pneumonia and gained significant attention during the COVID-19 pandemic for its efficacy in treating mild cases of the disease. The granules are composed of several herbal ingredients, including *Lonicera japonica*, *Forsythia suspensa*, and *Scutellaria baicalensis*, which are traditionally used for their heat-clearing and detoxifying properties. In February 2020, the Guangdong Provincial Drug Administration approved it as a hospital preparation for the clinical treatment of COVID-19.
- Brand names
- Feiyan Qingjie Granules
- Other names
- 肺炎清解颗粒Feiyan Qingjie Keli
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Feiyan Qingjie Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Feiyan Qingjie Granules.